130 related articles for article (PubMed ID: 6795779)
1. [Triquilar/Trinordiol. A new pill with 3 sequences].
Obel EB
Ugeskr Laeger; 1981 Jun; 143(25):1610-1. PubMed ID: 6795779
[No Abstract] [Full Text] [Related]
2. Elevation of serum prolactin during application of oral contraceptives.
Dericks-Tan JS; Taubert HD
Contraception; 1976 Jul; 14(1):1-8. PubMed ID: 975808
[No Abstract] [Full Text] [Related]
3. Progestational potency of oral contraceptives.
Dickey RP; Stone SC
Obstet Gynecol; 1976 Jan; 47(1):106-12. PubMed ID: 1246375
[TBL] [Abstract][Full Text] [Related]
4. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
Jespersen J; Kluft C
Scand J Clin Lab Invest; 1982 Nov; 42(7):563-6. PubMed ID: 6818678
[TBL] [Abstract][Full Text] [Related]
5. [Radioimmunological study of the effect of hormonal contraceptives upon the progesterone level of saliva (author's transl)].
Arnold M; Tóth I; Faredin I
Zahn Mund Kieferheilkd Zentralbl; 1980; 68(7):713-8. PubMed ID: 6163264
[No Abstract] [Full Text] [Related]
6. Multi-centre open study of a triphasic levonorgestrel-ethinyloestradiol combined oral contraceptive ('Trinordiol').
Butler AJ; Green A; Cohen M
Curr Med Res Opin; 1987; 10(8):503-13. PubMed ID: 2960493
[TBL] [Abstract][Full Text] [Related]
7. Effects of two triphasic oral contraceptives containing ethinylestradiol plus levonorgestrel or gestodene on blood coagulation and fibrinolysis.
Omsjø IH; Oian P; Maltau JM; Osterud B
Acta Obstet Gynecol Scand; 1989; 68(1):27-30. PubMed ID: 2508417
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study and effect on the uterine receptor of the combination Norgestrel-Ethinyl-Estradiol (FH 122-A) in 500 menstrual cycles].
Lévrier M
Bord Med; 1970 Jan; 3(1):225-6. PubMed ID: 4948561
[No Abstract] [Full Text] [Related]
9. Metabolic effects of a combination of dl-norgestrel and ethinylestradiol in humans.
Gerhards E; Lachnit U; Gaude R; Schillinger E
Arzneimittelforschung; 1973 Jun; 23(6):779-84. PubMed ID: 4740760
[No Abstract] [Full Text] [Related]
10. Central and peripheral parameters of the menstrual cycle under the influence of a new combined oral contraceptive.
Spona J; Schneider WH
Acta Obstet Gynecol Scand Suppl; 1976; 54():45-50. PubMed ID: 788444
[No Abstract] [Full Text] [Related]
11. One year study of effects of an oestrogen-dominant oral contraceptive on serum high-density lipoprotein cholesterol, apolipoproteins A-I and A-II and hepatic microsomal function.
Luoma PV; Heikkinen JE; Ehnholm C; Ylöstalo PR
Eur J Clin Pharmacol; 1987; 31(5):563-7. PubMed ID: 3104057
[TBL] [Abstract][Full Text] [Related]
12. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
Zellner P; Klinger G
Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
[No Abstract] [Full Text] [Related]
13. Clinical use of norgestrel-ethinyl oestradiol as a contraceptive.
Tyler ET; Matsner EM; Gotlib MH; Levin M; Daniels T; Shimabukuro B; Dolman H; Elliot J
J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:109-16. PubMed ID: 5288229
[No Abstract] [Full Text] [Related]
14. [Clinical studies on the SH 1000 as oral contraception (author's transl)].
Takayanagi M; Kamada M; Kushiki N; Lyo K; Fujiwara M
Nihon Funin Gakkai Zasshi; 1974 Oct; 19(4):36-45. PubMed ID: 4478828
[No Abstract] [Full Text] [Related]
15. D-norgestrel combined with ethinyl oestradiol as an oral contraceptive.
McBride WG
Curr Ther Res Clin Exp; 1970 Apr; 12(4):177-85. PubMed ID: 4985938
[No Abstract] [Full Text] [Related]
16. [Experimental use of the new generation of Tri-Step contraceptive agents in 20 treated cases].
Spasojević M
Med Arh; 1984; 38(2):83-4. PubMed ID: 6444082
[No Abstract] [Full Text] [Related]
17. Ultrastructure of cervical mucus and sperm penetration during use of a triphasic oral contraceptive.
Ulstein M; Myklebust RU
Acta Obstet Gynecol Scand Suppl; 1982; 105():45-9. PubMed ID: 6805245
[TBL] [Abstract][Full Text] [Related]
18. [Results of in vitro sperm penetration tests in cervical mucus under takings of the sequential oral contraceptive ovanon and sequilar (author's transl)].
Bregulla K; Fröhlich M
Arch Gynakol; 1977 Oct; 223(3):187-93. PubMed ID: 579297
[TBL] [Abstract][Full Text] [Related]
19. Uterine response to prostaglandin e2 under oral contraceptives.
Toppozada M; Khowessah M; Shaala S; Said S; Osman M
Contraception; 1976 Jun; 13(6):749-61. PubMed ID: 1277847
[No Abstract] [Full Text] [Related]
20. [Clinical trials of an association of norgestrel and ethinyl estradiol commercialized under the name of Stediril].
Gaudefroy M; Corette L; Coliche D
Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(4):434. PubMed ID: 5153231
[No Abstract] [Full Text] [Related]
[Next] [New Search]
